Why the study?
Does intracoronary streptokinase prevent myocardial infarction in patients with acute coronary artery occlusion complicating PTCA?
Does intracoronary streptokinase prevent myocardial infarction in patients with acute coronary artery occlusion complicating PTCA?
Intracoronary streptokinase can rapidly reopen acute coronary occlusions complicating PTCA, serving as a bridge to emergency bypass surgery to prevent myocardial infarction.
May support rapid reperfusion in PTCA occlusions as bridge to surgery; leaves open confirmation in controlled trials.
Percutaneous transluminal coronary angioplasty (PTCA) was complicated by acute coronary artery occlusion associated with ST elevation and severe chest pain in three patients. Within 10 minutes, the occluded artery was reopened by an intracoronary (i.c.) infusion of streptokinase, resulting in the disappearance of chest pain and normalization of ST segments. To keep the artery patent, i.c. streptokinase had to be continued until emergency bypass surgery was performed. In two patients, no myocardial infarction occurred, as shown by a normal postoperative left ventricular angiogram. ECG and thallium-201 scintigram. In the other patient, who was admitted with an inferior infarction and underwent PTCA after i.c. lysis, no infarct extension was observed. These results show that i.c. streptokinase rapidly opens an acute coronary artery occlusion complicating PTCA, preventing myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Schofer et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: